Vandetanib, 443913-73-3, 25 mg, Each
$ 148.93
|
Details
A broad spectrum, orally available kinase inhibitor that targets primarily tyrosine kinases, including VEGFR and EGFR, with IC50 values in the nanomolar range; also potently blocks non-receptor tyrosine kinases, including ABL, RET, and SRC, as well as several serine/threonine kinases 443913-73-3
Additional Information
SKU | 10229554 |
---|---|
UOM | Each |
UNSPSC | 41116105 |
Manufacturer Part Number | 1470625 |